{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:34:16Z","timestamp":1784309656080,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.psyneuen.2017.03.015","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T17:16:35Z","timestamp":1489857395000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Reduced ENA78 levels as novel biomarker for major depressive disorder and venlafaxine efficiency: Result from a prospective longitudinal study"],"prefix":"10.1016","volume":"81","author":[{"given":"Zezhi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daihui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2017.03.015_bib0005","series-title":"Psychoneuroimmunology","author":"Ader","year":"2007"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2004.09.007","article-title":"Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression","volume":"157","author":"Albright","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.01.004","article-title":"Neurotransmitter, peptide and cytokine processes in relation to depressive disorder, comorbidity between depression and neurodegenerative disorders","volume":"85","author":"Anisman","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1165\/rcmb.2011-0260OC","article-title":"Role of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposure","volume":"47","author":"Balamayooran","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","article-title":"Brain-immune communication pathways","volume":"21","author":"Banks","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0278-5846(02)00255-5","article-title":"Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance","volume":"26","author":"Benedetti","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.mcp.0000144502.50149.e0","article-title":"Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective","volume":"11","author":"Bisset","year":"2005","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajmg.b.30177","article-title":"Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders","volume":"135B","author":"Camp","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0045","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","article-title":"Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy","volume":"160","author":"Capuron","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0050","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1523\/JNEUROSCI.3357-07.2007","article-title":"Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration","volume":"27","author":"Ching","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0055","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","article-title":"Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation","volume":"29","author":"D'Mello","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: where do we stand?","volume":"15","author":"Dantzer","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","article-title":"Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity","volume":"500","author":"Dantzer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0080","first-page":"2182","article-title":"Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1(IL-1beta), IL-6, and tumor necrosis factor-alpha (TNF alpha), production in humans: high sensitivity of TNF alpha and resistance of IL-6","volume":"82","author":"DeRijk","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0b013e328315a561","article-title":"Inflammatory markers in depression","volume":"22","author":"Dinan","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0090","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","article-title":"Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression","volume":"62","author":"Felger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","article-title":"What is immune privilege (not)?","volume":"28","author":"Galea","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0100","doi-asserted-by":"crossref","first-page":"12970","DOI":"10.1523\/JNEUROSCI.2373-09.2009","article-title":"Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli","volume":"29","author":"Garcia-Bueno","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-5-15","article-title":"Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia","volume":"5","author":"Henry","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0110","doi-asserted-by":"crossref","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.psyneuen.2016.07.001","article-title":"Effects of interleukin-6, interleukin-18, and statin use, evaluated at acute stroke, on post-stroke depression during 1-year follow-up","volume":"72","author":"Kang","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.psyneuen.2017.03.015_bib0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0889-1591(02)00077-6","article-title":"Cytokine-induced sickness behavior","volume":"17","author":"Kelley","year":"2003","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-3223(03)00319-6","article-title":"Depressed new neurons\u2013adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression","volume":"54","author":"Kempermann","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0130","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jpsychires.2009.12.005","article-title":"Genome-wide linkage scans for major depression in individuals with alcohol dependence","volume":"44","author":"Kuo","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psyneuen.2009.06.007","article-title":"Serum chemokine levels in major depressive disorder","volume":"35","author":"Lehto","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.psyneuen.2012.05.005","article-title":"Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-\u03b1) in the Chinese patients with major depressive disorder: a prospective longitudinal study","volume":"38","author":"Li","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2012.10.003","article-title":"The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice","volume":"47","author":"Li","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.mp.4000586","article-title":"The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection","volume":"4","author":"Licinio","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.psyneuen.2016.11.031","article-title":"Oxidative stress, inflammation and treatment response in major depression","volume":"76","author":"Lindqvist","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2011.06.010","article-title":"Cytokines regulate neuronal gene expression: differential effects of Th1, Th2 and monocyte\/macrophage cytokines","volume":"238","author":"Lisak","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","article-title":"Evidence for an immune response in major depression: a review and hypothesis","volume":"19","author":"Maes","year":"1995","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0175","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpsychires.2005.11.003","article-title":"Cytokine profiles in women with different subtypes of major depressive disorder","volume":"41","author":"Marques-Deak","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0180","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0185","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2222.2003.01609.x","article-title":"Expression of the neutrophil-activating CXC chemokine ENA-78\/CXCL5 by human eosinophils","volume":"33","author":"Persson","year":"2003","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.WNF.0000220824.57769.E5","article-title":"Effect of amantadine on depressive symptoms in chronic hepatitis C patients treated with pegylated interferon: a randomized, controlled pilot study","volume":"29","author":"Quarantini","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0200","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1523\/JNEUROSCI.17-24-09473.1997","article-title":"Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice","volume":"17","author":"Raber","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","article-title":"Is depression an inflammatory disorder?","volume":"13","author":"Raison","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in major depressive disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000119332","article-title":"Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression","volume":"35","author":"Sluzewska","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0220","doi-asserted-by":"crossref","first-page":"76396","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy","volume":"2007","author":"Sutcigil","year":"2007","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0225","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jlb.62.5.604","article-title":"Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease","volume":"62","author":"Walz","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.biopsych.2006.10.016","article-title":"Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study","volume":"62","author":"Whooley","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0235","doi-asserted-by":"crossref","first-page":"e31283","DOI":"10.1371\/journal.pone.0031283","article-title":"Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder","volume":"7","author":"Yi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2017.03.015_bib0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-0-585-37970-8_16","article-title":"Cytokines, depression due to a general medical condition, and antidepressant drugs","volume":"461","author":"Yirmiya","year":"1999","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645301630837X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645301630837X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:57:49Z","timestamp":1759683469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645301630837X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":48,"alternative-id":["S030645301630837X"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.03.015","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced ENA78 levels as novel biomarker for major depressive disorder and venlafaxine efficiency: Result from a prospective longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}